I'm neither late or early, but it's a process.
Four months after a blood clot in his right shoulder ended his season without warning, 21-year-old Victor Wembanyama received medical clearance to return to basketball — a quiet but significant milestone in a recovery that offered no guarantees of timing. The condition, deep vein thrombosis in an unusual location for a player his age, required the kind of patience that cannot be scheduled or rushed. His return to the court now begins not with a dramatic comeback, but with the slow, deliberate work of rebuilding what absence takes away.
- A blood clot in Wembanyama's right shoulder ended his season abruptly in February, forcing one of basketball's most anticipated young stars into four months of complete inactivity.
- The rarity of a shoulder-based clot in a 21-year-old elevated medical concern well beyond what the league had seen in similar cases, making the Spurs' caution non-negotiable.
- Blood thinner treatment made a return date impossible to predict, leaving Wembanyama and the Spurs in a prolonged state of medical uncertainty with no fixed horizon.
- Clearance finally arrived on a Friday in July during NBA Summer League in Las Vegas — hours before Wembanyama told a reporter the news, visibly relieved.
- The path forward remains gradual: medically cleared does not mean game-ready, and the Spurs will ease him back through conditioning and preseason before any competitive return.
Victor Wembanyama received the news he had been waiting for on a Friday in July — San Antonio's medical staff had cleared him to return to basketball. Standing at the NBA Summer League in Las Vegas, the 21-year-old French center told a reporter the green light had come just hours earlier. "I'm officially cleared to return," he said. "Phew, I'll finally be able to play a bit of basketball again."
The road to that moment had been long and uncertain. In February, Wembanyama was diagnosed with deep vein thrombosis in his right shoulder — a blood clot that ended his season immediately and placed him in a recovery with no predictable endpoint. Unlike a fracture or a torn ligament, deep vein thrombosis is treated with blood thinners, medications that prevent clots from growing or traveling but offer no clean timeline for return. When asked about his condition in April, Wembanyama was measured: "We're taking our time. I'm neither late or early, but it's a process."
What set his case apart was both his age and the clot's location. Most NBA players who have faced deep vein thrombosis developed it in their legs — serious, but with more precedent in professional sports. A shoulder clot in someone so young was rarer and warranted extra caution. Damian Lillard faced a similar diagnosis just a month later, though in his leg, and managed a faster return — only to suffer a season-ending Achilles injury three games back, a sobering reminder of the risks that follow serious medical recovery.
Now cleared, Wembanyama faces a different kind of patience. The Spurs will bring him back gradually — through practice, conditioning, and preseason — rebuilding what four months away quietly erodes. The private chapter of his recovery is over; the visible one is just beginning.
Victor Wembanyama got the call he'd been waiting for on a Friday in July, four months after a blood clot forced him to walk away from basketball entirely. The San Antonio Spurs' medical staff had cleared him to play. The 21-year-old French center, standing on the sideline at the NBA Summer League in Las Vegas, told a reporter from L'Équipe that the green light had come just hours earlier. "I'm officially cleared to return," he said. "Phew, I'll finally be able to play a bit of basketball again."
Back in February, Wembanyama had been diagnosed with deep vein thrombosis in his right shoulder—a blood clot that ended his season abruptly and sent him into a recovery period with no clear endpoint. The Spurs had expected him to return in time for the next season, but the nature of his condition made precision impossible. Deep vein thrombosis is typically treated with blood thinners, medications that thin the blood to prevent clots from growing or traveling. That treatment protocol meant doctors couldn't simply predict a return date the way they might with a broken bone or a torn ligament. The timeline remained fluid, dependent on how his body responded.
For four months, Wembanyama had not touched a basketball in any meaningful way. He stayed away from team activities, from workouts, from the court. In April, when reporters asked how he was feeling, he offered a measured response: he was doing well, he said, but there was no rushing it. "We're taking our time," he explained. "I'm neither late or early, but it's a process." It was the kind of patience required when your body has developed a potentially serious condition, when the stakes of returning too soon are high.
What made Wembanyama's case particularly noteworthy was his age and the location of the clot. Most NBA players who have dealt with deep vein thrombosis developed it in their legs—a serious condition, but one with more historical precedent in professional basketball. A shoulder clot in a 21-year-old was rarer, and it had raised extra concern among medical professionals. The Spurs had to be cautious, had to let the process unfold without forcing it.
Wembanyama was not alone in this experience. Damian Lillard, the Milwaukee Bucks star, had been diagnosed with the same type of clot just one month after Wembanyama, though Lillard's was in his leg. Lillard had managed to return during the playoffs that season, a faster timeline than Wembanyama's. But Lillard's return came with its own complications—he suffered a season-ending Achilles injury just three games back on the court, a reminder that coming back from serious medical issues carries its own risks.
Now, with clearance in hand, Wembanyama faced a different kind of uncertainty. He was medically cleared to play, but that didn't mean he would immediately suit up for games. The Spurs would likely bring him along gradually, easing him back into basketball activities, rebuilding his conditioning and his feel for the game after four months away. The next chapter of his recovery was beginning, but it would unfold on the court, in practice, in preseason games—a slower, more visible process than the private rehabilitation that had come before.
Citações Notáveis
I'm officially cleared to return. Phew, I'll finally be able to play a bit of basketball again!— Victor Wembanyama to L'Équipe
We're taking our time. I'm neither late or early, but it's a process.— Victor Wembanyama in April 2025
A Conversa do Hearth Outra perspectiva sobre a história
Four months is a long time to be away from the sport you're built to play. Did Wembanyama seem frustrated during that stretch, or was he genuinely at peace with the process?
From what he said publicly, he seemed to accept it. That April comment—"I'm neither late or early"—that's not frustration talking. That's someone who understands that his body is the instrument, and you don't rush an instrument back into tune.
But there's something unusual about his case, right? The shoulder location, his age. Why did that matter so much medically?
Most NBA players who get deep vein thrombosis get it in their legs. There's a body of knowledge about that. A shoulder clot in a 21-year-old is less common, less predictable. The doctors had to be extra careful because they had fewer reference points.
And the blood thinners—that's what made the timeline so uncertain?
Exactly. You can't just say "six weeks" or "eight weeks" with blood thinners the way you might with a fracture. You're managing a chemical process in his body, watching how it responds. That's why the Spurs couldn't give a firm date.
Damian Lillard came back faster from a similar clot. Does that suggest Wembanyama was being overly cautious?
Lillard's was in his leg, different location. And Lillard came back and got hurt again—Achilles injury, three games in. Sometimes caution isn't overcaution. Sometimes it's the difference between a real recovery and a false start.
So what happens now that he's cleared? Does he just start playing?
No. Cleared to play and ready to play are different things. He'll ease back in—practice, preseason, gradually rebuilding what four months away takes from you. The clearance is the gate opening. Walking through it is another process entirely.